minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.0.0 - STU 2

This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.0.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

ValueSet: Cancer Staging System Value Set

Summary

Defining URL:http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-staging-system-vs
Version:2.0.0
Name:CancerStagingSystemVS
Title:Cancer Staging System Value Set
Status:Active as of 1/18/22 3:17 AM
Definition:

System used for staging.

Publisher:HL7 International Clinical Interoperability Council
Copyright:

This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement

Source Resource:XML / JSON / Turtle

References

Usage

The codes in this value set represent common TNM staging systems. Non-TNM staging systems are not currently represented in mCODE, reflecting mCODE’s current focus on solid tumors. This is not meant to constrain which staging systems are used. The bindings to this value set are extensible, meaning codes outside the value set can be used, if needed.

The codes themselves are drawn from both NCI Thesaurus and SNOMED CT, since the latter does not currently have a concept code denoting AJCC version 8, the most current version used for AJCC for cancer staging. AJCC is actively requesting the addition of new SNOMED CT concept code, although this process takes time.

Logical Definition (CLD)

 

Expansion

This value set contains 219 concepts

Expansion based on SNOMED CT United States edition 01-Sep 2021

All codes in this table are from the system http://snomed.info/sct

CodeDisplay
254292007Tumor staging
13808002WR stage 3
15972002WR stage 2
42114005WR stage 1
66470009WR stage 5
74542008WR stage 4
83200007WR stage 6
106242004Walter Reed staging of prostatic cancer
106244003FIGO staging of endometrial carcinoma
106245002FIGO staging of vulvar carcinoma
106246001FIGO staging of vulvar melanoma
106247005FIGO staging for epithelial tumor of ovary
106250008FIGO staging of cervical carcinoma
106252000Staging classification for lymphoma
110375007Overlapping tumor
254293002TNM tumor staging
254294008TNM Head and neck tumor staging
254295009TNM Lip and oral cavity tumor staging
254296005TNM Oropharynx tumor staging
254297001TNM Nasopharynx tumor staging
254298006TNM Hypopharynx tumor staging
254299003TNM Supraglottic larynx tumor staging
254300006TNM Glottic larynx tumor staging
254301005TNM Subglottic larynx tumor staging
254302003TNM Maxillary sinus tumor staging
254303008TNM Salivary glands tumor staging
254304002TNM Thyroid gland tumor staging
254305001TNM Digestive system tumor staging
254306000TNM Esophagus tumor staging
254307009TNM Stomach tumor staging
254309007TNM Small intestine tumor staging
254310002TNM Colon and rectum tumor staging
254311003TNM Anal canal tumor staging
254312005TNM Liver tumor staging
254313000TNM Gallbladder tumor staging
254314006TNM Extrahepatic bile ducts tumor staging
254315007TNM Ampulla of vater tumor staging
254316008TNM Pancreas tumor staging
254317004TNM Lung and pleural tumor staging
254318009TNM Lung tumor staging
254319001TNM Pleural mesothelioma tumor staging
254320007TNM bone and soft tissue tumor staging
254321006TNM Bone tumor staging
254322004TNM Soft tissues tumor staging
254323009TNM Skin tumor staging
254324003TNM Carcinoma of skin tumor staging
254325002TNM Malignant melanoma of skin staging
254326001TNM Breast tumor staging
254327005TNM Gynecological tumor staging
254328000TNM Vulva tumor staging
254329008TNM Vaginal tumor staging
254330003TNM Cervix uteri tumor staging
254331004TNM Corpus uteri tumor staging
254332006TNM Ovary tumor staging
254333001TNM Urological tumor staging
254334007TNM Penis tumor staging
254335008TNM Prostate tumor staging
254336009TNM Testis tumor staging
254337000TNM Kidney tumor staging
254338005TNM Renal pelvis and ureter tumor staging
254339002TNM Urinary bladder tumor staging
254340000TNM Urethra tumor staging
254341001TNM Ophthalmic tumor staging
254342008TNM Carcinoma of eyelid staging
254343003TNM Malignant melanoma of eyelid staging
254344009TNM Carcinoma of conjunctiva staging
254345005TNM Malignant melanoma of conjunctiva staging
254346006TNM Malignant melanoma of uvea staging
254347002TNM Malignant melanoma of iris staging
254348007TNM Malignant melanoma of ciliary body staging
254349004TNM Malignant melanoma of choroid staging
254350004TNM Retinoblastoma staging
254351000TNM Sarcoma of orbit staging
254352007TNM Lacrimal gland carcinoma staging
254353002TNM Brain tumor staging
254354008TNM Hodgkin's disease staging
254355009TNM Non-Hodgkin's lymphoma staging
254356005TNM Pediatric tumor staging
254357001TNM Wilms' tumor staging
254358006TNM Neuroblastoma staging
254359003TNM Soft tissue sarcoma staging
254360008Dukes staging system
254361007Astler-Coller staging system
254362000Modified Astler-Coller staging system
254363005International neuroblastoma staging system
254364004NWTS - National Wilms' tumor study staging system
254365003Siopel liver staging system
254366002Stannard staging system for retinoblastoma
254368001United Kingdom children's cancer study group central nervous system tumor staging system
254370005St Jude's malignant histiocytosis tumor staging system
254371009St Jude's non-Hodgkin's lymphoma staging system
254372002Ann Arbor lymphoma staging system
254373007Ann Arbor Hodgkin's disease tumor staging system
254374001Ann Arbor non-Hodgkin's lymphoma tumor staging system
254375000Cotswolds Hodgkin's disease tumor staging system
254376004Testicular tumor staging systems
254378003Walter Reed testicular tumor staging system
254379006Indiana University testicular tumor staging system
254380009Marshall Modification of Jewett-Strong staging system for urinary bladder tumor
254381008American Urological Association staging system for prostate cancer
254382001Trophoblastic malignancy staging system
254383006FIGO staging of gynecological malignancy
254384000FIGO Vaginal tumor staging
254385004Federation internationale de gynecologie et d'obstetrique staging of corpus uteri malignancy
254386003Federation Internationale de gynecologie et d'obstetrique staging of ovarian malignancy
258233007Generic tumor staging descriptor (tumor staging)
258234001TNM tumor staging classifications
258235000UICC
258236004AJCC
258244004G status
258246002L status
258247006V status
258257007Additional tumor staging descriptor (tumor staging)
258258002(f)
258259005is
258260000(d)
258267002Generic tumor risk status stages
258268007Low risk tumor
258269004Medium risk tumor
258270003High risk tumor
258271004Specific tumor staging descriptor (tumor staging)
258272006Liver tumor staging descriptor (tumor staging)
258273001Liver tumor size index
258276009Timing of liver tumor staging
258279002Lymphoma staging symptom status values
258280004Lymphomatous extranodal involvement status values
258281000S+ minimal
258282007S+ extensive
258283002Lymphomatous nodal involvement
258284008Stannards retinoblastoma stages
258285009Optic nerve tumor invasion status in retinoblastoma staging
258286005Choroidal tumor invasion status in retinoblastoma staging
258292004Lymph nodal tumor invasion status in retinoblastoma staging
258293009Brain tumor invasion status in retinoblastoma staging
258301001Langerhans cell histiocytosis stage (tumor staging)
258302008Number of organ systems involved with Langerhans cell histiocytosis
258303003Single system involvement
258304009Multisystem involvement
258305005Organ failure due to Langerhans cell histiocytosis
258306006Vital organ failure
258307002Non-vital organ failure
258309004Generic lymph node tumor invasion status stage (tumor staging)
258310009Neck node tumor involvement
258311008M+
258312001Axillary lymph node level
258313006Level I
258314000Midaxilla
258315004Level III
258316003Retroperitoneal lymph node tumor invasion status
258318002Generic anatomical site tumor invasion status
258319005Lung involvement stages
258320004Lung stage L2
258321000Lung stage L3
258322007H+
258323002Liver sectors
258324008Liver sector 1
258325009Liver sector 2
258326005Liver sector 3
258327001Liver sector 4
258328006Markers for liver tumor staging
261663004Tumor stage Ta
261731003CNS metastases
261789009Extra CNS metastases
261985008No metastases
277318003(m)
277645005Additional TNM descriptors
277646006a - At autopsy
277647002r - Tumor recurrence
277649004y - During therapy/following treatment
277650004m - Multiple tumors
277652007f - Family history
277676004d - Retinal involvement
278241006Node stage G1
278242004Node stage G2
278247005Lung stage L1
282402005V - Hepatic vein marker
282403000P - Portal vein marker
282404006E - Extrahepatic marker
282405007M - Metastatic marker
282436004E - Extralymphatic organ involvement marker
282437008S - Splenic involvement marker
313061008TNM Ethmoid sinus tumor staging
313118007TNM Fallopian tube tumor staging
313119004TNM Gestational trophoblastic tumor staging
385345007Clark system for melanoma staging (tumor staging)
385346008Breslow system for melanoma staging (tumor staging)
385359000Modified Dukes staging system (tumor staging)
417957003Uveal metastasis (tumor staging)
420417005Liver tumor size index more than 0.05 (tumor staging)
420483003Abdominal lymph node tumor invasion status A (tumor staging)
420533005Choroidal invasion stage C1 in retinoblastoma (tumor staging)
420728008Timing of liver tumor staging at diagnosis (tumor staging)
420841002Choroidal invasion stage C0 in retinoblastoma (tumor staging)
420889006Liver tumor size index less than 0.05 (tumor staging)
420969009Lymphoma staging symptom status A (tumor staging)
421074006Central nervous system stage B3 in retinoblastoma (tumor staging)
421174009Choroidal invasion stage C2 in retinoblastoma (tumor staging)
421188008Tumor staging descriptor r (tumor staging)
421211000Lymphoma staging symptom status B (tumor staging)
421294007Timing of liver tumor staging pre-surgery (tumor staging)
421426001Tumor staging descriptor a (tumor staging)
421432006Choroidal invasion stage C3 in retinoblastoma (tumor staging)
421655002Optic nerve invasion stage N1 in retinoblastoma (tumor staging)
421683000Optic nerve invasion stage N0 in retinoblastoma (tumor staging)
421745006Choroidal invasion stage C4 in retinoblastoma (tumor staging)
421755005Tumor staging descriptor y (tumor staging)
421824005Tumor staging descriptor p (tumor staging)
421838003Optic nerve invasion stage N3 in retinoblastoma (tumor staging)
421923000Central nervous system stage B2 in retinoblastoma (tumor staging)
422196000Tumor staging descriptor D (tumor staging)
422203007Central nervous system stage B1 in retinoblastoma (tumor staging)
443830009American Joint Commission on Cancer, Cancer Staging Manual, 7th edition neoplasm staging system (tumor staging)
444256004American Joint Commission on Cancer, Cancer Staging Manual, 6th edition neoplasm staging system (tumor staging)
706904009Tumor-node-metastasis (TNM) colon tumor staging
897275008American Joint Commission on Cancer, Cancer Staging Manual, 8th edition tumor staging system
1149099005Binet staging classification for chronic lymphocytic leukemia (tumor staging)
1149131009Rai staging system for chronic lymphocytic leukemia (tumor staging)
1149164009ACPS (Australian Clinico-pathological Staging) System for colorectal cancer
1149295006Malignant tumor staging (tumor staging)

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code